Abbreviation	Full term
AP site	apurinic/apyrimidinic site
ASO(s)	antisense oligonucleotide(s)
AuNP(s)	gold nanoparticle(s)
Cas9	CRISPR-associated protein 9
CHA	catalytic hairpin assembly
CLDz2	click-ligation deoxyribozyme 2 (DNAzyme-catalyzed triazole ligation)
COPD	chronic obstructive pulmonary disease
CRISPR	clustered regularly interspaced short palindromic repeats
CT	computed tomography
DMSO	dimethyl sulfoxide
Dz-seq (DZ-seq)	deoxyribozyme sequencing (high-throughput activity profiling by sequencing)
EPR	enhanced permeability and retention (effect)
FAM	6-carboxyfluorescein (fluorophore label)
GalNAc	N-acetylgalactosamine
G4	G-quadruplex
GATA-3	GATA binding protein 3
GPX4	glutathione peroxidase 4
HCR	hybridization chain reaction
HRV	human rhinovirus
HT-SELEX	high-throughput systematic evolution of ligands by exponential enrichment
LAMP	loop-mediated isothermal amplification
LFA	lateral flow assay
LNA	locked nucleic acid
lncRNA(s)	long non-coding RNA(s)
m1A	N1-methyladenosine
m6A	N6-methyladenosine
mRNA	messenger RNA
miRNA	microRNA
MOE	2′-O-methoxyethyl
MOF(s)	metal–organic framework(s)
MRI	magnetic resonance imaging
MsPA	mesyl phosphoramidate
NF-κB	nuclear factor kappa B
NIR	near-infrared
NLRP3	NLR family pyrin domain containing 3
PAGE	polyacrylamide gel electrophoresis
PCR	polymerase chain reaction
PD-L1	programmed death-ligand 1
PEG	polyethylene glycol
PET	positron emission tomography
PK-PD	pharmacokinetics/pharmacodynamics
PS	phosphorothioate
PDT	photodynamic therapy
RIP3	receptor-interacting protein kinase 3
RNA	ribonucleic acid
SB010	GATA-3 mRNA-targeting therapeutic DNAzyme candidate
SELEX	systematic evolution of ligands by exponential enrichment
SNP(s)	single-nucleotide polymorphism(s)
SuFEx	sulfur(VI) fluoride exchange
Th2	type 2 helper T
TNA	threose nucleic acid
TNF-α	tumor necrosis factor alpha
VEGF	vascular endothelial growth factor
VEGFR2	vascular endothelial growth factor receptor 2
XNA	xeno nucleic acid